<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5655D9DF-B87F-409E-9BD2-8CE1BDC910C3"><gtr:id>5655D9DF-B87F-409E-9BD2-8CE1BDC910C3</gtr:id><gtr:name>Cresset Biomolecular Discovery Limited</gtr:name><gtr:address><gtr:line1>Biopark Hertfordshire
Broadwater Road</gtr:line1><gtr:city>Welwyn Garden City</gtr:city><gtr:postCode>AL7 3AX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5655D9DF-B87F-409E-9BD2-8CE1BDC910C3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>5655D9DF-B87F-409E-9BD2-8CE1BDC910C3</gtr:id><gtr:name>Cresset Biomolecular Discovery Limited</gtr:name><gtr:address><gtr:line1>Biopark Hertfordshire
Broadwater Road</gtr:line1><gtr:city>Welwyn Garden City</gtr:city><gtr:postCode>AL7 3AX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>208850.0</gtr:offerGrant><gtr:projectCost>458210.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/66CB5717-9D16-439F-8700-FCC05E0EB599" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>66CB5717-9D16-439F-8700-FCC05E0EB599</gtr:id><gtr:name>Biolauncher Limited</gtr:name><gtr:address><gtr:line1>UNIT 20B BOURTON INDUSTRIAL PARK , BOURTON ON THE WATER</gtr:line1><gtr:city>CHELTENHAM</gtr:city><gtr:postCode>GL54 2HQ</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>121532.0</gtr:offerGrant><gtr:projectCost>202553.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1413403C-A236-4FC6-9044-DE20FA55D246" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>1413403C-A236-4FC6-9044-DE20FA55D246</gtr:id><gtr:name>Thomson Reuters (Scientific) Limited</gtr:name><gtr:address><gtr:line1>ALDGATE HOUSE , 33 ALDGATE HIGH STREET</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>EC3N 1DL</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>0.0</gtr:offerGrant><gtr:projectCost>0.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1BE1DEFA-A8A4-4E51-BE52-571502B10AE9"><gtr:id>1BE1DEFA-A8A4-4E51-BE52-571502B10AE9</gtr:id><gtr:firstName>Steve</gtr:firstName><gtr:surname>Gardner</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=100922"><gtr:id>46FAEA35-5430-4C4A-B874-353207A947F7</gtr:id><gtr:title>Exploiting data for drug reprofiling</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>100922</gtr:grantReference><gtr:abstractText>The project aims to create a platform through which the partners are able to offer products and services to customers in the area of drug re-profiling or re-purposing. Re-profiling generally consists of looking for a new therapeutic application for an existing drug molecule, or stated another way, searching databases of known drug molecules to find compounds which have high similarity to a query structure of interest. Cresset and Biolauncher bring together skills in computational chemistry, large-scale textual informatics and semantic data integration to create a system which enables the provision of applications and services in such re-profiling exercises to life sciences customers.</gtr:abstractText><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2011-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>330382</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">100922</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>